Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person said. Bain Capital has been riding a growing wave of Japanese mergers and acquisitions in ...

[HONG KONG] Bain Capital is looking to raise billions of US dollars for ... It also agreed to buy medical firm Mitsubishi Tanabe Pharma. Private equity fundraising in Asia has slowed down as the ...

Bain Capital LP has entered into a definitive agreement with ... Following the closing of the transaction, Tanabe Pharma will continue to develop innovative medical technologies to enhance research ...

The company is selling Mitsubishi Tanabe Pharma, its pharmaceutical business, to the US private equity firm Bain Capital and is offloading $2.6 billion worth of other operations. CEO Manabu ...

JERSEY CITY, N.J., April 3, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced 11 presentations will be shared at the American Academy of Neurology (AAN) 2025 Annual ...

BOSTON & CHARLESTON, S.C., April 21, 2025--(BUSINESS WIRE)--Bain Capital’s Real Estate team ("Bain Capital") and BlueWater Marinas ("BlueWater"), led by Joe Miller and Dunston Powell ...

Mumbai: Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure Pharmaceuticals Ltd through a substantial block deal, according to two ...

Packaging and storage are crucial in pharma supply chains. Businesses in the segment have attracted several PE firms, including 1315 Capital ... have some insights by Bain & Company on the ...

April 17 (Reuters) - Australia's Insignia Financial (IFL.AX), opens new tab said on Thursday that it has extended the exclusivity period by four weeks for both its bidders, Bain Capital and CC ...